Global Pharmaceutical Sales Grew 5% to $386 billion; U.S. Share $196 billion

Global pharmaceuticals sales through retail pharmacies increased 5% to $386.23 billion in 13 key markets in the 12-month period from November 2005 through to November 2006, according to IMS Retail Drug Monitor. 

Sales figures are at ex-manufacturer prices and include all prescription and certain over-the-counter data.Figures include sales from the hospital sector in Japan and mail order in the USA. 

  • Sales in the top five European markets showed a 4% constant exchange growth.
  • North America posted a 7% sales growth at $209.98 billion in sales in the 12 months to November.  The U.S. accounted for $196.2 billion in sales.
  • Japan's overall growth was flat at 0% growth in the $56.78 billion market. 

Cardiovascular continues to be the single largest therapeutic category with global sales of over $75 billio, followed by central nervous system $72.7 billion. 

The best selling drug for the 12 months ending November 2006 was Lipitor, worth over $11.62 billion, with a decreased growth at 3.7%. Nexium still has the largest growth at the top with 16.2%.

The top 5 drugs in the year to November 2006:

1. Lipitor
2. Nexium
3. Seretide
4. Plavix
5. Norvasc

The top 5 corporations in the year to November 2006:

1. Pfizer
2. GlaxoSmithKline
3. Novartis
4. AstraZeneca
5. Merck & Co.

Previous: « ATLANTIC-ACM: Market for Business VoIP and IP VPN to Reach $15 billion by 2012

Next : » The Best of Latest IT Market Intelligence from IDC


  ABOUT    CONTACT Metrics 2.0 RSS Feeds RSS   Metrics 2.0 Widgets for your site or blog WIDGETS   ARCHIVES


Enter Email for Daily Feed Delivery: